Vnitr Lek 2013, 59(8):694-697

Liver transplants in viral hepatitides

L. Husová
Centrum kardiovaskulární a transplantační chirurgie Brno, ředitel doc. MUDr. Petr Němec, CSc.

The authors present their own results of liver transplants over the last 30 years (from 2 February 1983 to 31 December 2012). For the respective period, 451 patients underwent a transplant in the Brno Transplantation Centre. Ten out of 451 patients (2.2%) underwent transplants for the indication of cirrhosis caused by viral hepatitis B in the Brno Transplantation Centre. The first liver transplant indicated due to viral hepatitis B was performed in 1994. Out of the ten patients, 3 died (30%). Forty-one out of 451 patients (9%) underwent liver transplant for cirrhosis caused by viral hepatitis C. The first liver transplant indicated due to viral hepatitis B was performed in 1991. A total of 21 patients out of 41 (51%) were treated with antiviral therapy; 27 out of 41 (66%) developed a recurrence after the liver transplant. Out of the 41 patients who underwent a liver transplant for viral hepatitis C indication, a total of 15 (36.6%) died.

Keywords: orthotopic liver transplantation; indication; cirrhosis; hepatitis B virus; hepatitis C virus

Received: April 2, 2013; Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husová L. Liver transplants in viral hepatitides. Vnitr Lek. 2013;59(8):694-697.
Download citation

References

  1. ©perl J. Transplantace jater pro virové hepatitidy. In: Trunečka P, Adamec M et al (eds). Transplantace jater. Praha: Karolinum 2009: 63-74.
  2. Killenberg PG, Clavin PA. Medical Care of the Liver Transplant Patient. New York: Blackwell Publishing 2006. Go to original source...
  3. Francoz C, Belghiti J, Durand F. Indications of liver transplantation in patients with complications of cirrhosis. Best Pract Res Clin Gastroenterol 2007; 21: 175-190. Go to original source... Go to PubMed...
  4. Terrault N. Liver transplantation in the petting of chronic HCV. Best Pract Res Clin Gastroenterol 2012; 26: 531-548. Go to original source... Go to PubMed...
  5. Gane EJ, Patterson S, Strasser SI et al. Combination of lamivudine and adefovir without hepatitis B imine globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transpl 2013; 19: 268-274. Go to original source... Go to PubMed...
  6. Husa P. Trojkombinační léčba chronické hepatitidy C. Vnitř Lék 2012; 58: 588-590. Go to PubMed...
  7. Coilly A, Roche B, Samuel D. Current management and perspectives for HCV recurrence after liver transplantation. Liver Int 2012; 33 (Suppl 1): 56-62. Go to original source... Go to PubMed...
  8. Coilly A, Roche B, Dumortier J et al. Efficacy and safety of protease inhibitors for severe Hepatitis C recurrence after liver transplantation: a first multicentric experience. J Hepatol 2012; 56 (Suppl 2): 21. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.